| Financial Year |
March 31 2023 |
| Monetary Funds |
360,389,608.92 |
| Held-for-trading Financial Assets |
147,201,789.86 |
| Notes Receivable |
-- |
| Accounts Receivable |
338,170,770.98 |
| Advances to Suppliers |
190,220,663.20 |
| Other Receivables |
15,902,291.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
13,787,533.29 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
20,820,168.51 |
| Total Current Assets |
1,086,492,826.15 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
19,590,972.59 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
206,913.15 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,376,195.76 |
| Deferred Income Tax Assets |
15,663,698.88 |
| Other Non-Current Assets |
200,315,112.19 |
| Sub-Total of Non-Current Assets |
243,294,131.66 |
| Total Assets |
1,329,786,957.81 |
| Short-Term Loans |
24,905,555.56 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
44,208,564.72 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,122,830.72 |
| Taxes Payable |
17,182,699.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
960,240.61 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
2,457,784.88 |
| Other Current Liabilities |
2,993,495.14 |
| Sub-Total of Current Liabilities |
145,533,346.65 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
645,610.54 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,181,395.15 |
| Total Liabilities |
146,714,741.80 |
| Paid-In Capital(Or Share Stock) |
80,000,000.00 |
| Capital Surplus |
811,886,654.12 |
| Surplus Reserve |
26,975,063.65 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
265,093,918.40 |
| Minority Stockholder's Interest |
-883,420.16 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,183,955,636.17 |
| Owner's Equity（Stockholder's Equity） |
1,183,072,216.01 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,329,786,957.81 |
